In response to the ongoing spread of the monkeypox virus, the American Medical Association (AMA) has released coding guidance for laboratory testing and vaccine administration. The new codes are effective for immediate use. The laboratory test describes the molecular diagnostic testing that detects the nucleic signature of an orthopoxvirus, while the vaccine codes describe the two smallpox and monkeypox virus products currently available.
87593: Infectious agent detection by nucleic acid (DNA or RNA); orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each
90622: Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, for percutaneous use
90611: Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free, 0.5 mL dosage, suspension, for subcutaneous use
Visit the AAFP website to stay up to date on monkeypox.
— Erin Solis, manager of practice and payment, American Academy of Family Physicians
Posted on August 2, 2022, by Erin Solis
Sign up to receive FPM's free, weekly e-newsletter, "Quick Tips & Insights," featuring practical, peer-reviewed advice for improving practice, enhancing the patient experience, and developing a rewarding career.